2224 related articles for article (PubMed ID: 25711406)
1. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
2. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
3. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A; Effendy I; Frey Tirri B; Hof H; Mayser P; Petricevic L; Ruhnke M; Schaller M; Schaefer APA; Sustr V; Willinger B; Mendling W
Mycoses; 2021 Jun; 64(6):583-602. PubMed ID: 33529414
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
6. [Fungal diseases of vulva and vagina caused by Candida species].
Stock I
Med Monatsschr Pharm; 2010 Sep; 33(9):324-33; quiz 335-6. PubMed ID: 21192442
[TBL] [Abstract][Full Text] [Related]
7. [Vulvovaginal mycoses].
Mendling W
Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):175-9. PubMed ID: 9606884
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
10. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Kunzelmann V; Tietz HJ; Rossner D; Czaika V; Hopp M; Schmalreck A; Sterry W
Mycoses; 1996; 39 Suppl 1():65-72. PubMed ID: 8767274
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Gomez-Moyano E; Cid Lama A; Fernández Ballesteros MD; Lova Navarro M; Vera Casaño A; Crespo Erchiga V
Rev Iberoam Micol; 2013 Jan; 30(1):61-3. PubMed ID: 22885618
[TBL] [Abstract][Full Text] [Related]
12. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
13. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
Danby CS; Boikov D; Rautemaa-Richardson R; Sobel JD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1403-6. PubMed ID: 22232293
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
[TBL] [Abstract][Full Text] [Related]
16. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
19. [Vaginal candidiasis--treatment protocols using miconazole and fluconazole].
Mazneĭkova V
Akush Ginekol (Sofiia); 2003; 42 Suppl 2():30-4. PubMed ID: 14619753
[TBL] [Abstract][Full Text] [Related]
20. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
